Kirloskar Hospital

Name :

Kirloskar Hospital

Address  :

5-9-47/4, Bashir Bagh
Opp Gandhi Medical College

Town  :

Hyderabad

State  :

Telangana

Country  :

INDIA

Post Code:

500063

Phone  :

040 - 23296241, 23230633, 6661142

Fax  :

040 - 23296245

Web URL  :

Kirloskar Hospital
Specialization
  • Colour Doppler
  • Daibetes, Endocrinology
  • Gastro-enterology
  • Gynaecology
  • Video Laproscopic Surgery
  • X-Ray
Facilities

Speciality Type :

Multi Speciality :

  • Surgical Endoscopic
  • Gynaecology

Other Facilities

  • Pathology
  • X-Ray
  • CT/MRI

Description

About Us
Kirloskar Hospitals Diabetic Surgery Team

Surgeons Dr Surendra Ugale Dr TS Kumar DrNageswar Rao Dr Vasisht Satwalekar and Dr Neeraj Gupta
Anesthesia amp Intensive Care Endocrinologists Diabetic Specialists Physician amp Nutritionist Clinical Psychologist amp Psychiatrist amp Chest Physician
Brief CV of Dr Surendra Ugale


Medical education and postgraduation from Bombay University
Specialised training in Gastrointestinal surgery amp Endoscopic work with Prof VN Shrikhande amp Dr AG Nande in Mumbai
Started private practice in HYD at Kirloskar Hospital 20 yrs ago1988
1st to start Laparoscopic surgery in AP state in 1991
Started training surgeons in Laparoscopy all over India by doing workshops amp operations till date more than 400 surgeons have been trained
Promoted team approach for better surgical workDr Neeraj amp Dr Vishwas joined to form team since 15 years
Team doing all advanced laparoscopic surgeries weightloss surgery amp now also Diabetic surgery
Renal denervation may come to India soon

Even as the incidence of hypertension increases in India doctors are contemplating the use of quotsympathetic renal denervationquot a procedure used to treat resistant systemic hypertension Resistant hypertension is when high blood pressure cannot be controlled even after using three to four medicines one of which has to be a diuretic a med... Read More

Group B Neisseria meningitidis Vaccine Shows Promise

An investigational vaccine may represent a strong lead in the fight against group B Neisseria meningitidis according to results of a phase 2 study published online in the Lancet Administered in 3 doses over the course of 6 months a new bivalent vaccine was well tolerated and induced a strong immune response against multiple strains of the poten... Read More